Covered recipient · General Payments record
RAFAEL F MEDINA-PRIETO
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2019–2023
$2,503.93
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $990.36 | 19 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $654.60 | 11 |
| GENZYME CORPORATION | $139.70 | 1 |
| E.R. Squibb & Sons, L.L.C. | $108.46 | 3 |
| Janssen Pharmaceuticals, Inc | $47.60 | 2 |
| Amgen Inc. | $40.00 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.90 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893371 | CMS |
| ABBVIE INC. | $25.00 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893373 | CMS |
| ABBVIE INC. | $25.00 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893375 | CMS |
| ABBVIE INC. | $33.67 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893377 | CMS |
| ABBVIE INC. | $25.00 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893379 | CMS |
| ABBVIE INC. | $100.48 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893381 | CMS |
| ABBVIE INC. | $26.57 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893383 | CMS |
| ABBVIE INC. | $114.52 | 05/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893385 | CMS |
| ABBVIE INC. | $125.00 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893387 | CMS |
| ABBVIE INC. | $25.00 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893389 | CMS |
| ABBVIE INC. | $124.46 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997893391 | CMS |
| Amgen Inc. | $20.00 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020060375 | CMS |
| Amgen Inc. | $20.00 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020060377 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.62 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016296337 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.11 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016296443 | CMS |
| E.R. Squibb & Sons, L.L.C. | $61.73 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016296447 | CMS |
| GENZYME CORPORATION | $139.70 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050360309 | CMS |
| Janssen Pharmaceuticals, Inc | $23.80 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987947297 | CMS |
| Janssen Pharmaceuticals, Inc | $23.80 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987947305 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.